NCT00135486View on ClinicalTrials.gov

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants

PHASE2CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL

MenC-TT

BIOLOGICAL

Hib-MenC-TT

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY